These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8233719)

  • 1. Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis.
    Levy E; Gurbindo C; Lacaille F; Paradis K; Thibault L; Seidman E
    Pediatr Res; 1993 Aug; 34(2):162-6. PubMed ID: 8233719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
    Grunfeld C; Pang M; Doerrler W; Shigenaga JK; Jensen P; Feingold KR
    J Clin Endocrinol Metab; 1992 May; 74(5):1045-52. PubMed ID: 1373735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
    Bershad S; Rubinstein A; Paterniti JR; Le NA; Poliak SC; Heller B; Ginsberg HN; Fleischmajer R; Brown WV
    N Engl J Med; 1985 Oct; 313(16):981-5. PubMed ID: 2931603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients.
    Lévy E; Lepage G; Bendayan M; Ronco N; Thibault L; Galéano N; Smith L; Roy CC
    J Lipid Res; 1989 Aug; 30(8):1197-209. PubMed ID: 2769073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein metabolism in postmenopausal and oophorectomized women.
    Wakatsuki A; Sagara Y
    Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
    Antikainen M; Holmberg C; Taskinen MR
    Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of EFA deficiency and tumor necrosis factor-alpha on circulating lipoproteins in rats.
    Levy E; Delvin E; Peretti N; Bouchard G; Seidman E
    Lipids; 2003 Jun; 38(6):595-602. PubMed ID: 12934668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
    Blackett PR; Lee DM; Donaldson DL; Fesmire JD; Chan WY; Holcombe JH; Rennert OM
    Pediatr Res; 1984 Sep; 18(9):864-70. PubMed ID: 6483510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of increases in dietary fat intake on plasma lipid and lipoprotein cholesterol concentrations and associated enzyme activities in cats.
    Butterwick RF; Salt C; Watson TD
    Am J Vet Res; 2012 Jan; 73(1):62-7. PubMed ID: 22204289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of lipoprotein lipase gene in tissues of the rat model with visceral obesity and postprandial hyperlipidemia.
    Hikita M; Bujo H; Yamazaki K; Taira K; Takahashi K; Kobayashi J; Saito Y
    Biochem Biophys Res Commun; 2000 Oct; 277(2):423-9. PubMed ID: 11032739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men.
    Giada F; Baldo-Enzi G; Balocchi MR; Zuliani G; Baroni L; Fellin R
    Int J Sports Med; 1988 Aug; 9(4):270-4. PubMed ID: 3141306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
    Goldberg AP; Applebaum-Bowden DM; Bierman EL; Hazzard WR; Haas LB; Sherrard DJ; Brunzell JD; Huttunen JK; Ehnholm C; Nikkila EA
    N Engl J Med; 1979 Nov; 301(20):1073-6. PubMed ID: 226883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined (n-3 and n-6) essential fatty deficiency is a potent modulator of plasma lipids, lipoprotein composition, and lipolytic enzymes.
    Levy E; Thibault L; Garofalo C; Messier M; Lepage G; Ronco N; Roy CC
    J Lipid Res; 1990 Nov; 31(11):2009-17. PubMed ID: 2086700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.